FDA Commissioner Scott Gottlieb Resigns

​Food and Drug Administration commissioner Scott Gottlieb has announced his resignation on Wednesday. According to a letter penned to FDA staff, Gottlieb said he is resigning to spend more time with family. 

Gottlieb has found respect in an industry that typically has distaste for regulators. In his first year as commissioner, Gottlieb approved a record number of new and generic drugs. Executives in the biopharma industry have described Gottlieb as “a great commissioner who oversaw the continued modernization of the FDA and the approval of many innovative medicines” and “open and willing to work with innovators.”
​
Before resigning, Gottlieb was faced with the daunting tasks of curbing underage smoking and the growing opioid crisis.